The SPC Blog has received news
from Tarik Kapic of Bovard of a decision from the Swiss Federal Administrative
Court that will force the Swiss Institute of Intellectual Property to decide
whether an SPC can be granted on a stent eluting an active ingredient. An
application was filed in 2014 but the Institute refused completely to enter
into the matter and the Court has now accepted the appeal based on a “denial of
justice” (Rechtsverweigerung).
A copy of the decision can be
found here. Unfortunately no English translation is available at the
moment.
Many thanks to Tarik for passing
this on!
No comments:
Post a Comment